Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Exchange Rate Effect: 2009-2017

Historic Exchange Rate Effect for UNITED THERAPEUTICS (UTHR) over the last 7 years, with Sep 2017 value amounting to -$200,000.

  • UNITED THERAPEUTICS's Exchange Rate Effect rose 80.00% to -$200,000 in Q3 2017 from the same period last year, while for Sep 2017 it was -$3.6 million, marking a year-over-year increase of 18.18%. This contributed to the annual value of $200,000 for FY2017, which is 106.67% up from last year.
  • As of Q3 2017, UNITED THERAPEUTICS's Exchange Rate Effect stood at -$200,000, which was down 0.00% from -$200,000 recorded in Q4 2016.
  • In the past 5 years, UNITED THERAPEUTICS's Exchange Rate Effect registered a high of $1.5 million during Q2 2015, and its lowest value of -$3.1 million during Q1 2015.
  • In the last 3 years, UNITED THERAPEUTICS's Exchange Rate Effect had a median value of -$1.0 million in 2016 and averaged -$944,444.
  • The largest annual percentage gain for UNITED THERAPEUTICS's Exchange Rate Effect in the last 5 years was 374.68% (2015), contrasted with its biggest fall of 1,912.99% (2015).
  • UNITED THERAPEUTICS's Exchange Rate Effect (Quarterly) stood at -$295,000 in 2013, then tumbled by 892.54% to -$2.9 million in 2014, then skyrocketed by 45.36% to -$1.6 million in 2015, then soared by 87.50% to -$200,000 in 2016, then surged by 80.00% to -$200,000 in 2017.
  • Its last three reported values are -$200,000 in Q3 2017, -$200,000 for Q4 2016, and -$1.0 million during Q3 2016.